Martin Shkreli Quotes


If you have a drug that is $100 for one course of therapy, and you know that you can charge $100,000, what should shareholders think when you say, 'I'd rather not take the heat'?


Citations

Herper, Matthew. "Martin Shkreli At The Forbes Healthcare Summit." Forbes, Forbes Media, 3 Dec. 2015.

Related Quotes

His father Cornelius, one of the great, creative industrialists of America, was not at all of the same mindset and saw corporations and the Railroads as having an important role in America with substantial obligations to the society which enabled the economic development and supported the railroads. He described his son as a “blockhead”. William goes down in American history as the arrogant industrialist and capitalist whose wealth was produced by his talent of being born to the right father who built the great empire.


This is the definition of good business that most conservative a business interests prefer. They do not wish to differentiate among the businesses nor do they wish to imply that businesses have any other obligations or desirable characteristics. By this definition, a business that makes money producing adult pornography is as good as one that develops pharmaceuticals; one that creates well paying jobs is as good as one that creates minimum wage jobs or even exports jobs overseas. Complying with the law in a democracy has never been a definition of good citizenship. It is a minimum duty to which all are obliged some businesses enhance the quality of life; others diminish it. This is where many differ with Mr. Longworth.


Martin Shkreli
Martin Shkreli
  • Born: March 17, 1983
  • Nationality: American
  • Profession: Co-founder MSMB Capital Management, Co-founder Former CEO Retrophin, Founder Former CEO Turing Pharmaceuticals

Martin Shkreli, called "Pharma Bro" by some media, is an American former hedge fund manager and convicted felon. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare; the co-founder and former chief executive officer (CEO) of the pharmaceutical firms Retrophin and Turing Pharmaceuticals (now Vyera Pharmaceuticals); and the former CEO of start-up software company Gödel Systems, which he founded in August 2016.